Get started
Author

Brooke M. Jennings

Observed names: Brooke Jennings, Brooke M Jennings
ORCID: 0000-0003-4751-7288
Observed ORCID: 0000-0003-4751-7288
OpenAlex ID: A5075486514
Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma
2019 · Charlotte R. Feddersen, Jacob L. Schillo, et al. · Cancer Research · 25
PDF
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
2021 · John M. Rieth, Umang Swami, et al. · Cancers · 13
PDF
Diagnosis and management of immune checkpoint inhibitor-associated adrenal insufficiency: A single-institution experience
2025 · Brooke Jennings, Andrea Arenz, et al. · Journal of Oncology Pharmacy Practice · 2
Sustained response to imatinib in patient with extraskeletal myxoid chondrosarcoma and novel KIT mutation
2021 · Brooke Jennings, John Rieth, et al. · BMJ Case Reports · 2
PDF
552 Targeting RNA hypermethylation to restore immunoproteasome function: a phase I trial of 5-azacitidine plus PD-1/PD-L1 inhibitor in patients with PD-1/PD-L1 refractory solid tumors
2026 · Brooke M Jennings, Elizabeth Hannan, et al. · Journal for ImmunoTherapy of Cancer
PDF
SAT-325 Unveiling a Rare Complication: Transverse Myelitis Arising After Osseous Trans Arterial Chemoembolization (TACE) for Follicular Thyroid Carcinoma Metastases
2025 · Brooke Jennings, Aiman Riaz · Journal of the Endocrine Society
PDF
Supplementary Data from Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma
2023 · Charlotte R. Feddersen, Jacob L. Schillo, et al.
Supplemental Tables from Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma
2023 · Charlotte R. Feddersen, Jacob L. Schillo, et al.
Data from Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma
2023 · Charlotte R. Feddersen, Jacob L. Schillo, et al.
Supplementary Data from Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma
2023 · Charlotte R. Feddersen, Jacob L. Schillo, et al.
PDF
Data from Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma
2023 · Charlotte R. Feddersen, Jacob L. Schillo, et al.
Supplemental Tables from Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma
2023 · Charlotte R. Feddersen, Jacob L. Schillo, et al.
A Curious Case of Diarrhea, Pancreatitis, and Rash
2022 · Brooke Jennings, Andrew Bryant · The American Journal of Medicine
Effects of Pak Kinase Inhibition on Emergence of Vemurafenib Resistance in Melanoma
2018 · Brooke M. Jennings · Iowa Research Online (The University of Iowa)
PDF
Works count: 15
Citation count: 42
H-index: 2
I10-index: 2
Year
Topic
Type